Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-046314
Filing Date
2023-04-17
Accepted
2023-04-17 17:28:24
Documents
4
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2312833d1_def14a.htm PRE 14A 279038
2 GRAPHIC tm2312833d1_def14aimg001.jpg GRAPHIC 17985
3 GRAPHIC tm2312833d1_proxyimg001.jpg GRAPHIC 149247
4 GRAPHIC tm2312833d1_proxyimg002.jpg GRAPHIC 203416
  Complete submission text file 0001104659-23-046314.txt   790989
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39202 | Film No.: 23824890
SIC: 2834 Pharmaceutical Preparations